Maravai LifeSciences Holdings, Inc. (MRVI) Stock Overview
Explore Maravai LifeSciences Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Maravai LifeSciences Holdings, Inc. (MRVI)
Key Financials
Key Financials
Market Cap
2.3B
P/E Ratio
-15.62
EPS (TTM)
$-0.19
ROE
-0.35%
MRVI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Maravai LifeSciences Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MRVI on the NASDAQ shows an RSI of 74.27, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $10.68 for the NASDAQ listing.
Key metrics behind Maravai LifeSciences Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -15.62 and a market capitalization of 2.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MRVI on the NASDAQ.